Todd E. Simpson - 16 Feb 2023 Form 4 Insider Report for Seagen Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Feb 2023, 18:35:49 UTC
Prior SEC filing
01 Sep 2022
Next SEC filing
28 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ Jennifer Prosba For: Todd E Simpson

Key filing fact

Todd E. Simpson filed Form 4 for Seagen Inc. on 21 Feb 2023.

Key facts

  • This page summarizes Todd E. Simpson's Form 4 filing for Seagen Inc..
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 21 Feb 2023, 18:35.

Change

  • Previous filing in this sequence was filed on 01 Sep 2022.
  • Current net transaction value: -$4,827,514.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGEN transaction

Common Stock

Options Exercise

Transaction value
$1,563,886
Shares
+39,946
Change %
+29%
Price
$39.15
Shares after
177,131
Date
16 Feb 2023
Ownership
Direct
Footnotes
F1
SGEN transaction

Common Stock

Sale

Transaction value
$6,391,400
Shares
-39,946
Change %
-23%
Price
$160.00
Shares after
137,185
Date
16 Feb 2023
Ownership
Direct
Footnotes
F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SGEN transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-39,946
Change %
-100%
Price
$0.000000*
Shares after
0
Date
16 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
39,946
Exercise price
$39.15
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.

Footnote F2

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Footnote F3

Reflects sales of common stock executed in multiple transactions at prices ranging from $160.00 to $160.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Footnote F4

Options vested at a rate of 25% on 8/25/2016 and monthly thereafter until all the options were fully vested on 8/25/19.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .